Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: The example of methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4410-4416

  Kardas Słoma, Lidia ^a,b   Boëlle, Pierre Yves ^b,c,d   Opatowski, Lulla ^e,f,g,h   Guillemot, Didier ^e,f,h,i   Temime, Laura ^a  

^a University of Paris Cité   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e INSTITUT PASTEUR   (France)

^f INSERM U657   (France)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

ⁱ RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CLINDAMYCIN; MACROLIDE; METICILLIN; QUINOLONE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; COMMUNITY; FRANCE; HOSPITAL; INTENSIVE CARE UNIT; MATHEMATICAL MODEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; SIMULATION;

ANTI-BACTERIAL AGENTS; DRUG INTERACTIONS; FRANCE; HUMANS; INTENSIVE CARE UNITS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MODELS, STATISTICAL; STAPHYLOCOCCAL INFECTIONS;

EID: 84882300224     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00711-13     Document Type: Article

References (29)

1. Barbosa TM, Levy SB. 2000. The impact of antibiotic use on resistance development and persistence. Drug Resist. Updat. 3:303-311.
2. Charbonneau P, Parienti JJ, Thibon P, Ramakers M, Daubin C, du Cheyron D, Lebouvier G, Le Coutour X, Leclercq R. 2006. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin. Infect. Dis. 42:778-784.
3. Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY, Watier L, Guillemot D. 2009. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 6:e1000084. doi:10.1371/journal.pmed.1000084.
4. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. 2008. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J. Antimicrob. Chemother. 61:26-38.
5. Huttner B, Goossens H, Verheij T, Harbarth S. 2010. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect. Dis. 10:17-31.
6. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS). June 2011, posting date. Dix ans d'évolution des consommations d'antibiotiques en France. http://ansm.sante.fr/var/ansm-site/ storage/original/application/263354f238b8f7061cdb52319655ca07.pdf.
7. Madaras-Kelly KJ, Remington RE, Lewis PG, Stevens DL. 2006. Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect. Control Hosp. Epidemiol. 27:155-169.
8. Parienti JJ, Cattoir V, Thibon P, Lebouvier G, Verdon R, Daubin C, du Cheyron D, Leclercq R, Charbonneau P. 2011. Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis. J. Hosp. Infect. 78: 118-122.
9. Harbarth S, Samore MH. 2008. Interventions to control MRSA: high time for time-series analysis? J. Antimicrob. Chemother. 62:431-433.
10. Burke JP. 1998. Antibiotic resistance-squeezing the balloon? JAMA 280: 1270-1271.
11. Kardas-Sloma L, Boelle PY, Opatowski L, Brun-Buisson C, Guillemot D, Temime L. 2011. Impact of antibiotic exposure patterns on selection of community-associated methicillin-resistant Staphylococcus aureus in hospital settings. Antimicrob. Agents Chemother. 55:4888-4895.
12. Kajita E, Okano JT, Bodine EN, Layne SP, Blower S. 2007. Modelling an outbreak of an emerging pathogen. Nat. Rev. Microbiol. 5:700-709.
13. Stefani S, Chung DR, Lindsay JA, Friedrich AW, Kearns AM, Westh H, Mackenzie FM. 2012. Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int. J. Antimicrob. Agents 39:273-282.
14. David MZ, Daum RS. 2010. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23:616-687.
15. Mera RM, Suaya JA, Amrine-Madsen H, Hogea CS, Miller LA, Lu EP, Sahm DF, O'Hara P, Acosta CJ. 2011. Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microb. Drug Resist. 17:321-328.
16. Temime L, Kardas-Sloma L, Opatowski L, Brun-Buisson C, Boëlle P-Y, Guillemot D. 2010. NosoSim: an agent-based model of nosocomial pathogens circulation in hospitals. Procedia Comput. Sci. 1:2245-2252.
17. Cooper BS, Medley GF, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Duckworth G, Lai R, Ebrahim S. 2004. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc. Natl. Acad. Sci. U. S. A. 101:10223-10228.
18. Ficca G, Chauvel M, de Mouy D. 2006. Prevalence of communityacquired methicillin-resistant Staphylococcus aureus. Med. Mal. Infect. 36: 207-212. (In French.)
19. Thibaut S, Caillon J, Lepelletier D, Lombrail P, Potel G, Ballereau F. 2010. Who are the carriers of MRSA in the community? A prospective study in the Pays de la Loire region of France. Clin. Microbiol. Infect. 16:915-920.
20. European Antimicrobial Resistance Surveillance System (EARSS). August 2003, posting date. Annual report 2002. EARSS, Bilthoven, Netherlands. http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Documents/ 2002-EARSSAnnual-Report.pdf.
21. Patry I, Leroy J, Henon T, Talon D, Hoen B, Bertrand X. 2008. Evaluation of antibiotic prescription in a French university hospital. Med. Mal. Infect. 38:378-382. (In French.)
22. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM. 2003. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect. Control Hosp. Epidemiol. 24:362-386.
23. Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlet G, Buu-Hoi A, Carlet J, Decre D, Gottot S, Gutmann L, Joly-Guillou ML, Legrand P, Nicolas-Chanoine MH, Soussy CJ, Wolf M, Lucet JC, Aggoune M, Brucker G, Regnier B. 2010. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch. Intern. Med. 170: 552-559.
24. Opatowski L, Guillemot D, Boelle PY, Temime L. 2011. Contribution of mathematical modeling to the fight against bacterial antibiotic resistance. Curr. Opin. Infect. Dis. 24:279-287.
25. Donker T, Wallinga J, Grundmann H. 2010. Patient referral patterns and the spread of hospital-acquired infections through national health care networks. PLoS Comput. Biol. 6:e1000715. doi:10.1371/journal.pcbi .1000715.
26. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. 2004. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc. Natl. Acad. Sci. U. S. A. 101:3709-3714.
27. Huang SS, Datta R, Rifas-Shiman S, Kleinman K, Placzek H, Lankiewicz JD, Platt R. 2011. Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study. Crit. Care 15:R210. doi:10.1186/cc10445.
28. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Communityassociated meticillin-resistant Staphylococcus aureus. Lancet 375:1557-1568.
29. Miller MB, Weber DJ, Goodrich JS, Popowitch EB, Poe MD, Nyugen V, Shope TR, Foster DT, Miller JR, Kotch J. 2011. Prevalence and risk factor analysis for methicillin-resistant Staphylococcus aureus nasal colonization in children attending child care centers. J. Clin. Microbiol. 49: 1041-1047.